FMCG major Emami is reportedly in final stage of negotiations with SBS Biotech to buy Kesh King brand. The talks are hovering around a deal size of Rs 1,800 crore and the companies are targeting to sign on the dotted line by May-end if talks succeed.
It will be a large transaction for Emami if the deal goes through, but, the company has shown interest in many large deals in the past showing its appetite to expand inorganically. It will need to raise funds for the buyout and equity fund raising cannot be ruled out.
Kesh King is owned by Himachal Pradesh-based SBS Biotech and has revenues of over Rs 400 crores. Emami reported a rise of 14.89% in its net profit at Rs 132.34 crore for the quarter ended March 31, 2015 as compared to Rs 115.19 crore for the same quarter in the previous year.
| Company Name | CMP |
|---|---|
| Hindustan Unilever | 2241.10 |
| Godrej Consumer Prod | 1108.20 |
| Dabur India | 442.10 |
| Colgate Palmol. (I) | 2106.20 |
| P&G Hygiene | 10006.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: